Biotech · Private company
Kaleido Biosciences
Track this companyFree. Adds Kaleido Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- KB195Phase 2 · Urea Cycle DisorderClinicalTrials.gov · fetched Nov 12, 2026
- KB109Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- KB109 + Self Supportive CareCOVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- KB109 + Self Supportive Care (SSC)Mild-to-moderate COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- KB174Early CirrhosisClinicalTrials.gov · fetched Nov 12, 2026
- KB195HealthyClinicalTrials.gov · fetched Nov 12, 2026
- KB295Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- KB5HealthyClinicalTrials.gov · fetched Nov 12, 2026
- LactuloseHealthyClinicalTrials.gov · fetched Nov 12, 2026
- MaltodextrinHealthyClinicalTrials.gov · fetched Nov 12, 2026
- MaltodextrinEarly CirrhosisClinicalTrials.gov · fetched Nov 12, 2026
- No interventionVancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- PolydextroseHealthyClinicalTrials.gov · fetched Nov 12, 2026
- PullulanHealthyClinicalTrials.gov · fetched Nov 12, 2026
- Self Supportive Care (SSC) AloneCOVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Self Supportive Care (SSC) AloneMild-to-moderate COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- SG1HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120COMPLETED · started Mar 25, 2021ClinicalTrials.gov NCT04814914 · fetched Nov 12, 2026
- A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and FunctionNA · COMPLETED · started Jan 12, 2021ClinicalTrials.gov NCT04486482 · fetched Nov 12, 2026
- A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and FunctionNA · COMPLETED · started Aug 12, 2020ClinicalTrials.gov NCT04508413 · fetched Nov 12, 2026
- A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19NA · COMPLETED · started Aug 2, 2020ClinicalTrials.gov NCT04414124 · fetched Nov 12, 2026
- UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle DisorderPHASE2 · TERMINATED · started Sep 17, 2019ClinicalTrials.gov NCT03933410 · fetched Nov 12, 2026
- VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant OrganismsNA · TERMINATED · started Jun 27, 2019ClinicalTrials.gov NCT03944369 · fetched Nov 12, 2026
- Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated CirrhosisNA · COMPLETED · started Feb 27, 2019ClinicalTrials.gov NCT03855956 · fetched Nov 12, 2026
- A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy SubjectsNA · COMPLETED · started Sep 18, 2017ClinicalTrials.gov NCT04603378 · fetched Nov 12, 2026
- A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy SubjectsNA · COMPLETED · started Sep 11, 2017ClinicalTrials.gov NCT04619875 · fetched Nov 12, 2026